Efficacy and Tolerability of a Fixed-Dose Combination of Metoprolol Extended Release/Amlodipine in Patients with Mild-to-Moderate HypertensionA Randomized, Parallel-Group, Multicentre Comparison with Losartan plus Amlodipine

被引：0
|
作者：
Anil Pareek
Nitin B. Chandurkar
Ravishankar Sharma
Dharmendra Tiwari
Bhagwan S. Gupta
机构：
[1] Ipca Laboratories Ltd,Medical Affairs and Clinical Research
[2] Ipca Laboratories Limited,Clinical Research and Development
[3] NSCB Medical College and Hospitals,Department of Medicine
[4] G.R. Medical College and J.A. Group of Hospitals,Department of Medicine
[5] SMS Medical College and Hospital,Department of Medicine
来源：
Clinical Drug Investigation | 2010年 / 30卷
关键词：
Metoprolol; Losartan; Amlodipine; Calcium Channel Antagonist; Amlodipine Group;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: Epidemiological studies and clinical trials have shown that prevention of cardiovascular disease, the ultimate goal of hypertension treatment, requires a sufficient reduction in blood pressure.
引用
收藏
页码：123 / 131
页数：8
相关论文
共 50 条
  • [41] Results of a comparative, phase III, 12-week, multicenter, prospective, randomized, double-blind assessment of the efficacy and tolerability of a fixed-dose combination of telmisartan and amlodipine versus amlodipine monotherapy in Indian adults with stage II hypertension
    Sharma, Akhilesh
    Bagchi, Ananda
    Kinagi, Satish B.
    Sharma, Yogesh Kumar
    Baliga, Vidyagauri P.
    Bollmall, Chandrashekhar
    CLINICAL THERAPEUTICS, 2007, 29 (12) : 2667 - 2676
  • [42] Antihypertensive efficacy of metoprolol XL/Low dose chlorthalidone (6.25 mg) combination: a randomized, comparative study in Indian patients with mild-to-moderate essential hypertension
    A Pareek
    SD Zawar
    SB Salagre
    NB Chandurkar
    ND Karnik
    European Journal of Medical Research, 14
  • [43] ANTIHYPERTENSIVE EFFICACY OF METOPROLOL XL/LOW DOSE CHLORTHALIDONE (6.25 mg) COMBINATION: A RANDOMIZED, COMPARATIVE STUDY IN INDIAN PATIENTS WITH MILD-TO-MODERATE ESSENTIAL HYPERTENSION
    Pareek, A.
    Zawar, S. D.
    Salagre, S. B.
    Chandurkar, N. B.
    Karnik, N. D.
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2009, 14 (07) : 297 - 303
  • [44] Comparative Efficacy and Safety Profile of Amlodipine 5 mg/Losartan 50 mg Fixed-Dose Combination and Amlodipine 10 mg Monotherapy in Hypertensive Patients Who Respond Poorly to Amlodipine 5 mg Monotherapy: An 8-Week, Multicenter, Randomized, Double-Blind Phase III Noninferiority Study
    Kang, Seok-Min
    Youn, Jong-Chan
    Chae, Shung Chull
    Park, Chang Gyu
    Yang, Joo Young
    Kim, Moo Hyun
    Hong, Taek Jong
    Kim, Cheol Ho
    Kim, Jae Joong
    Shin, Dong Gu
    Jung, Jin Won
    Yoon, Jung Han
    Park, Si Hoon
    Kwon, Jun
    Cho, Seung Yun
    CLINICAL THERAPEUTICS, 2011, 33 (12) : 1953 - 1963
  • [45] Consistent efficacy in both men and women of a fixed-dose valsartan plus hydrochlorothiazide combination therapy compared with amlodipine monotherapy in hypertensive patients with additional cardiovascular risk factors
    Heintz, Daniela
    Malacco, Ettore
    Ruilope, Luis M.
    Stolt, Pelle
    Kandra, Albert
    Brandao, Andraea
    Khder, Yasser
    JOURNAL OF HYPERTENSION, 2006, 24 : 205 - 205
  • [46] Consistent efficacy of a fixed-dose valsartan plus HCTZ combination therapy vs amlodipine in obese and non-obese hypertensive patients with additional cardiovascular risk factors
    Brandao, A. A.
    Heintz, D.
    Ruilope, L. M.
    Malacco, E.
    Kandra, A.
    Khder, Y.
    JOURNAL OF HYPERTENSION, 2006, 24 : S165 - S165
  • [47] A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of the Extended-Release Tramadol Hydrochloride/Acetaminophen Fixed-Dose Combination Tablet for the Treatment of Chronic Low Back Pain
    Lee, Jae Hyup
    Lee, Chong-Suh
    CLINICAL THERAPEUTICS, 2013, 35 (11) : 1830 - 1840
  • [48] Comparison of the Efficacy and Safety of Fixed-dose S-Amlodipine/Telmisartan and Telmisartan in Hypertensive Patients Inadequately Controlled with Telmisartan: A Randomized, Double-blind, Multicenter Study
    Park, Chang Gyu
    Tae Hun Ahn
    Cho, Eun Ju
    Kim, Won
    Kim, Hyung Seob
    Yang, Ju Yeong
    Ryu, Jae Geun
    Kim, Cheol Ho
    Hyeon, Min Soo
    Tak, Seung Je
    Im, Se Jung
    Ha, Jong Won
    Pyeon, Wook Beom
    Jae, Je Geon
    Han, Gyu Rok
    Doh, Jun Hyung
    Im, Sang Wook
    Lee, Myeong Muk
    CLINICAL THERAPEUTICS, 2016, 38 (10) : 2185 - 2194
  • [49] Efficacy and safety of acarbose plus metformin fixed-dose combination versus acarbose monotherapy for type 2 diabetes: a randomised, double-blind, parallel-group study
    Wang, J. -S.
    Huang, C. -N.
    Hung, Y. -J.
    Kwok, C. -F.
    Sun, J. -H.
    Pei, D.
    Yang, C. -Y.
    Chen, C. -C.
    Lin, C. -L.
    Sheu, W. -H.
    DIABETOLOGIA, 2013, 56 : S389 - S389
  • [50] Efficacy and safety of a fixed-dose combination of dapagliflozin and linagliptin (AJU-A51) in patients with type 2 diabetes mellitus: A multicentre, randomized, double-blind, parallel-group, placebo-controlled phase III study
    Hong, Jun Hwa
    Kim, Myung Jin
    Min, Kyung Wan
    Won, Jong Chul
    Kim, Tae Nyun
    Lee, Byung-Wan
    Kang, Jun Goo
    Kim, Jae Hyeon
    Park, Jung Hwan
    Ku, Bon Jeong
    Lee, Chang Beom
    Kim, Sang Yong
    Shon, Ho Sang
    Lee, Woo Je
    Park, Joong-Yeol
    DIABETES OBESITY & METABOLISM, 2025, 27 (01): : 81 - 91
12345